This laboratory was inaugurated by Dr. Silke Krol, Italy in 2012. Basic research on cancer cells was started with
the aim to translate the therapeutic non-invasive modalities from bench to bedside. PRL has initiated Photodynamic therapy
(PDT) on different cancer cells for the first time in the country in collaboration with National Institute of Health (NIH),
Pakistan and Harvard Medical School, USA for better therapeutic outcome. Different therapeutic modalities such as PDT, chemo,
medicinal etc., alone and in combination were administered on different human cancer cell lines i.e., HeLa, RD, Hep2c, and Hep2.
Researcher from other universities are utilizing this laboratory frequently and are always warmly welcomed to work in PRL Lab
on research problems related to the field of Photodynamic therapy.
Photonanomedicine Research Laboratory has gained a lot of attention of researchers in a very short time due to its significant
contributions on various projects related to cancer therapy. PRL also won funding under NRPU for development of polymeric nano-carrier.
Currently, the main focused is on polymeric nano-drug delivery due to its biocompatibility and biodistribution.
We are also plan to divert our expertise in computational model for biomedical application.